Novo Nordisk drugs

20 results

  • alhemo

    (concizumab)
    Novo Nordisk
    Alhemo is indicated for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients aged 12 and older with hemophilia A (factor VIII deficiency with inhibitors) and hemophilia B (factor IX deficiency with inhibitors).
    Medication Details

  • levemir

    (insulin detemir)
    Novo Nordisk
    LEVEMIR is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. However, it is not recommended for treating diabetic ketoacidosis.
    Medication Details
    Drug Interactions

  • macrilen

    (Macimorelin acetate)
    Novo Nordisk
    MACRILEN is used for diagnosing adult growth hormone deficiency (AGHD). Its safety and diagnostic effectiveness in individuals with a body mass index (BMI) greater than 40 kg/m² have not been established.
    Medication Details

  • norditropin

    (somatropin)
    Novo Nordisk
    NORDITROPIN is indicated for pediatric patients with growth failure from inadequate growth hormone secretion, short stature due to Noonan or Turner syndrome, short stature born SGA, Idiopathic Short Stature, and Prader-Willi syndrome. For adults, it is used to replace endogenous growth hormone in those with deficiency.
    Medication Details
    Drug Interactions

  • ozempic

    (semaglutide)
    Novo Nordisk
    OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events and helps in preventing kidney disease progression in patients with type 2 diabetes and chronic kidney disease.
    Medication Details
    Drug Interactions

  • rivfloza

    (nedosiran)
    Novo Nordisk
    RIVFLOZA is indicated for lowering urinary oxalate levels in children aged 2 years and older and adults with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function (eGFR ≥30 mL/min/1.73 m²).
    Medication Details